Baxter International (BAX) Cash & Current Investments (2009 - 2026)
Baxter International (BAX) reported Cash & Current Investments of $2.0 billion for Q1 2026, down 11.94% year-over-year from $2.3 billion in Q1 2025, and up 2.75% quarter-over-quarter from $2.0 billion in Q4 2025.
Baxter International (BAX) Cash & Current Investments (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Cash & Current Investments data on file, last reported at $2.0 billion in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $2.0 billion, down 11.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 billion (down 11.94% YoY), and the FY2025 annual result was $2.0 billion, up 11.45% from the prior year.
- Cash & Current Investments climbed to $2.0 billion in Q1 2026 per BAX's latest filing, from $2.0 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $5.7 billion in Q3 2023 and troughed at $1.4 billion in Q3 2024.
- A 5-year average of $2.2 billion and a median of $1.8 billion in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments surged 257.03% in 2023, then tumbled 75.16% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $1.6 billion in 2022, then jumped by 89.88% to $3.1 billion in 2023, then slumped by 42.69% to $1.8 billion in 2024, then grew by 11.45% to $2.0 billion in 2025, then gained by 2.75% to $2.0 billion in 2026.
- Business Quant data shows BAX's Cash & Current Investments at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 229.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 1.97 Bn |
| Sep 30, 2025 | 1.73 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 1.76 Bn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 2.83 Bn |
| Dec 31, 2023 | 3.08 Bn |
| Sep 30, 2023 | 5.72 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.85 Bn |
| Mar 31, 2022 | 2.29 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 3.26 Bn |
| Jun 30, 2021 | 3.14 Bn |